Overview

Aio

(fl. c. 952—960) supposed historian


'Aio' can also refer to...

AIO

AIO

AIO dimensions

AIO [Airline]

AIO dimensions

AIO [Airport Code]

aio Lat v

Aio (fl. 950x975), supposed historian

AiO, combining DNA/protein programs and oligo-management

Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)†

O-0030INDEPENDENT RADIOLOGICAL EVALUATION OF OBJECTIVE RESPONSE EARLY TUMOR SHRINKAGE, AND DEPTH OF RESPONSE IN FIRE-3 (AIO KRK-0306)

Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

PD-027BRAF mutant and RAS mutant patients treated with FOLFIRI plus Bevacizumab or FOLFIRI plus Cetuximab. Role of ETS and molecular markers in FIRE-3 (AIO KRK-0306)

Pharmacogenetic analyses of hematotoxicity in advanced gastric cancer patients receiving biweekly fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group

O-0029FOLFIRI PLUS CETUXIMAB VERSUS FOLFIRI PLUS BEVACIZUMAB AS FIRST-LINE TREATMENT OF KRAS-WILDTYPE METASTATIC COLORECTAL CANCER: GERMAN AIO STUDY KRK-0306 (FIRE-3)

O-0003P-ERK, P-AKT AND P53 AS TISSUE BIOMARKERS IN ERLOTINIB-TREATED PATIENTS WITH ADVANCED PANCREATIC CANCER: A TRANSLATIONAL SUBGROUP ANALYSIS FROM AIO-PK0104

P-0126NEONAX: NEOADJUVANT PLUS ADJUVANT OR ONLY ADJUVANT NAB-PACLITAXEL PLUS GEMCITABINE FOR RESECTABLE PANCREATIC CANCER: A PHASE II STUDY OF THE AIO PANCREATIC CANCER GROUP

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

 
Show Summary Details

Quick Reference


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.